Head of Strategic Planning

Rare disease, genetic medicine, and the opportunity to help build a company that is making a real difference for patients who have been overlooked by the industry for too long.

You bring 8 to 12+ years of experience in strategic planning, management consulting, or investment banking, with meaningful exposure to the biopharmaceutical or life sciences sector.

Experience at a top-tier strategy firm (McKinsey, BCG, Bain or equivalent) is strongly preferred.

You understand how pipeline assets are valued, how competitive dynamics play out in rare disease markets, and what separates a credible long-range strategic plan from a wishful one.

You have developed and presented Board-level strategy materials.

You know what a sophisticated Board expects and how to deliver it.

Strategy at BridgeBio is not a support function.

The Head of Strategic Planning will partner directly with the Chief Strategy Officer & Chief Legal Officer to shape the corporate strategy of one of the most productive rare disease companies in the industry.

This person will be at the center of BridgeBio’s most important strategic questions, focusing on organizational long-range strategic planning and strategic prioritization.

They will be a key author of the materials that bring answers to life for senior audiences inside and outside the company.

Reporting directly to the Chief Strategy Officer and Chief Legal Officer, you will have meaningful visibility into the company’s strategic decisions and a genuine voice in shaping them as you build trust and demonstrate impact.

BridgeBio is at an inflection point.